Adjuvant Multiagent Chemotherapy Regimens Associated with OS Benefit Following Resection of Localised Pancreatic Adenocarcinoma Following Preoperative (m)FOLFIRINOX By Ogkologos - March 11, 2025 899 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a retrospective cohort study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate ESMO and ASCO publish joint consensus statement on streamlining clinical research FDA Grants Accelerated Approval to Camizestrant with a CDK4/6 Inhibitor for ESR1-Mutated HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer MOST POPULAR Study Finds Possible New Treatment for Metastatic Breast Cancer That Has... January 29, 2022 After a Generous Donor Covered Her Bills, Breast Cancer Survivor Raises... December 22, 2020 News digest – targeted drug approval, microbubble ‘warheads’ and prostate cancer... June 27, 2020 Today is Giving Tuesday December 1, 2020 Load more HOT NEWS Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App Hormone Therapy Has A Stronger Impact On A Woman’s Quality Of... Change Your Thoughts, Change Your World NEPA Plus Dexamethasone Provide Superior Chemotherapy-Induced Nausea and Vomiting Prevention Compared...
